Haploidentical bone marrow transplant with posttransplant cyclophosphamide for sickle cell disease: An update

Hematopoietic cell transplant (HCT) can cure both children and adults with sickle cell disease. Outcomes have historically been poor for the vast majority of patients who lack a matched sibling donor. However, the development of haploidentical HCT (haplo-HCT) with high doses of posttransplant cyclop...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hematol Oncol Stem Cell Ther
Hauptverfasser: Patel, Dilan A., Akinsete, Adeseye M., de la Fuente, Josu, Kassim, Adetola A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: King Faisal Specialist Hospital & Research Centre. Published by Elsevier Ltd. 2020
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7118612/
https://ncbi.nlm.nih.gov/pubmed/32202252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hemonc.2020.01.002
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge